A Mycobacterium leprae expression library was constructed in the vectors EX1, pEX2, and pEX3 and screened with a pool of 19 well-absorbed sera from household contacts of leprosy patients. Twelve selected recombinants that were further characterized differed clearly from recombinants selected with murine monoclonal antibodies. Whereas the monoclonal antibodies recognized mainly six recombinant antigens, the human sera from contacts reacted with a range of different recombinant antigens. None of the contact recombinant antigens was identical or related to well-characterized antigens from M. leprae or other mycobacteria selected with monoclonal antibodies, including proteins of the heat shock families. Two groups of recombinant antigens could be distinguished: one that was recognized by all sera used in the pool and one that was recognized by only a limited number of sera. These antigens, selected with sera from household contacts of previously untreated lepromatous leprosy patients, may be relevant to the immune responses during the early phase of infection with M. leprae.
Leprosy is still a major health problem in many parts of the world; despite the great efforts that have been made to better control the disease, the prevalence of the disease remains at a constant level (41) . Studies on the immunology of leprosy have mainly focused on clinical aspects of the disease. Relatively little is known about the immunological events during the preclinical phase of the disease.
Serological studies among household contacts of leprosy patients, in which higher seropositivity rates were reported than the incidence rates expected in these populations, suggest that seropositivity reflects subclinical infection (2, 12) . Considering the low sensitivity of these tests when relatively small numbers of bacilli are present (2) , the seropositive contacts are probably only a small proportion of the total pool of infected individuals. The dynamics of infection would likely be, as for many other infectious diseases, as follows. A person becomes colonized with Mycobacterium leprae and subsequently either gets rid of the bacterium or becomes infected (invasion of tissue by bacteria). Subsequently, the individual could either overcome the infection (by an effective immune response or by treatment) or develop the disease. Little is known about the factors that determine the dynamics of infection. Available methodology to determine the immunological status of infected individuals lacks either sensitivity, as in the case of serological tests (2, 13) , or specificity, as in the case of the lepromin skin test (41) . However, it is important to broaden our knowledge of the immunological reactions during the early stages of infection. Such information could, for example, lead to the identification of antigens involved in protection or in pathogenesis and, equally important, may result in the development of new tools for the detection of preclinical leprosy.
Most of the recombinant antigens from M. leprae were * Corresponding author.
initially identified either with murine monoclonal antibodies (45) or with sera from diseased individuals (9, 29) . However, the immune responses in inbred mice and in persons with clinical leprosy may well be distinct from those during early infection. As a first step to identify antigens that may play a role during the early phase of infection with M. leprae, we screened an M. leprae gene library with sera obtained from household contacts of untreated multibacillary leprosy patients. These contacts, who had lived in close proximity with the index cases for several years, are likely to be infected with M. leprae. In this report we describe the selection and characterization of recombinant clones obtained with such sera.
MATERIALS AND METHODS
Strains and plasmids. M. leprae was isolated from spleen tissue of experimentally infected armadillos (Dasypus novemcintus Linn.) as recommended by the World Health Organization (40) . Escherichia coli K-12 strain POP2136 was used as a host for construction of recombinant plasmids and for gene expression. POP2136 is a nonexcisable lambda lysogenic strain carrying the cI ts856 gene (Genofit, Geneva, Switzerland). Strain S1036 is POP2136 carrying plasmid pEX2. Plasmids pEX1, pEX2, and pEX3 have been described by Stanley and Luzio (34) .
Media and reagents. Strain POP2136 and derivatives were grown in LB medium (22 Sera were pooled and extensively absorbed as described by Sathish et al. (29) . Briefly, the pool of sera was incubated overnight at 4°C with whole POP2136 and heat-induced S1036 cells. Subsequently, the pool was absorbed over columns of lysates of strain POP2136, heat-induced strain S1036, and purified beta-galactosidase from E. coli (Sigma) coupled to cyanogen bromide (CNBr)-activated Sepharose 4B (Sigma). The pool was subjected to four cycles of absorption. Pooled sera were used at a final dilution of 1:200 in blocking buffer (see below) to screen the libraries. Absorption of individual sera was essentially done by the same procedure, except that the elution over the columns was omitted.
DNA technology. Standard procedures were used for restriction enzyme digestion, ligation, and transformation (22) . Preparation of genomic DNA from nonirradiated M. leprae was done as described previously (15) . DNA sequencing of the pEX1, pEX2, and pEX3 derivatives was done by the dideoxy-chain termination method (28) with a T7 sequencing kit (Pharmacia LKB, Uppsala, Sweden) and a Thermalbase Taq sequencing kit (Stratagene, La Jolla, Calif.). For DNA sequencing, plasmid DNAs were isolated by alkaline extraction (5) and further purified by CsCl gradient centrifugation or by use of the Geneclean kit (BIO 101, La Jolla, Calif.).
Synthetic oligonucleotides S10 (CAACATCAGCCGCT ACAGTC), 86.25-2 (GGCGACGACTCCTGGAGCCCG), and 17.5.88-2 (CAGCAAGCTTGGCTGCAGGTCG) were used as primers for DNA sequencing. Primers S10 and 86.25-2 are homologous to the region of lacZ from 145 to 125 base pairs (bp) and 33 to 12 bp, respectively, upstream of the EcoRI site (18) . Primer 17.5.88-2 is homologous to the region 13 to 35 bp downstream of this EcoRI site in pEX2 (34) . All primers were synthesized on a 381A DNA synthesizer (Applied Biosystems) and were used without further purification.
For dot blot hybridization, 1-,ug samples of plasmid DNA were spotted onto Duralose-UV membranes (Stratagene). The subsequent procedure was essentially the same as for colony hybridization (22) . Insert DNA used as a probe was excised from hybrid plasmids with Sail and SmaI. Small insertion fragments (100 to 400 bp) were amplified as previously described (15) with oligonucleotides 86.25-2 and 17.5.88-2 as the set of primers in the amplification reaction.
Amplified fragments were cleaved with Sall and SmaI.
Unique cleavage sites for these restriction enzymes are positioned to the left and right of the BamHI cloning site of the pEX plasmid vectors. Fragments were separated by electrophoresis on agarose gels and isolated from the agarose with the Geneclean kit. Some of the DNA inserts apparently contained one or more Sall-SmaI cleavage sites, since more than one insert fragment was visible on the agarose gels. Preparation of 32P-labeled probe DNA was done with a random priming DNA labeling kit (Boehringer) according to the instructions of the manufacturer. Additionally, probe DNA was labeled by using a DNA digoxigenindUTP labeling and detection kit (Boehringer). Prehybridization, hybridization, and washing of all membranes were done as described previously (15) . DNASIS and PROSIS software (Pharmacia LKB) was used for the homology search of nucleotide and amino acid sequences.
Construction of the M. leprae expression libraries in pEX1, pEX2, and pEX3. M. leprae genomic DNA was partially digested with Sau3A as follows: 5 U of Sau3A was added to 10 ,ug of M. Ieprae DNA in 100 RI1 of Sau3A buffer. After 30, 60, and 120 s of incubation at 37°C, samples of 30 ,u1 were taken and immediately transferred to phenol saturated with 10 mM Tris hydrochloride (pH 8.0)-10 mM EDTA to stop the reaction. After phenol-ether extraction, DNA was recovered by ethanol precipitation. Two fractions (30 and 60 s) contained fragments of 0.5 to 4 kbp, judged from electrophoretic patterns of the fractions on agarose gels. These fractions were pooled and used for cloning into the pEX plasmids.
Samples ( Filters were then incubated overnight with the pooled sera and washed again in wash buffer before incubation with alkaline phosphatase-labeled anti-human immunoglobulins diluted 1:500 in blocking buffer. The filters were then washed and developed in substrate buffer (100 mM Tris hydrochloride [pH 9.6]-100 mM NaCl-50 mM MgCl2 containing 0.1 mg of nitro blue tetrazolium grade III per ml and 0.05 mg of 5-bromo-4-chloro-3-indolylphosphate per ml).
Immunological techniques. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was done on 8% acrylamide gels as described by Laemmli (21) , and Western immunoblotting was done by the method of Burnette (7) as modified by Van Embden et al. (38) . For dot blot analysis, 5 p.1 of lysate (optical density at 600 nm, 5) was spotted onto nitrocellulose or Immobilon-P (Millipore B.V., Etten-Leur, The Netherlands) membranes. Substrate buffer for alkaline phosphatase-labeled anti-human immunoglobulins was as described above for the colony enzyme-linked immunosorbent assay.
RESULTS
M. leprae expression library. Restriction enzyme analysis of plasmid DNA isolated from randomly picked colonies of the gene libraries in pEX1, pEX2, and pEX3 revealed that approximately 40% of the plasmids contained an M. leprae DNA insert larger than 400 bp, with a mean of about 1.0 kbp.
Colony hybridization with 32P-labeled M. Ieprae genomic DNA as a probe showed that up to 60% of the plasmids contained an M. leprae DNA insert. Apparently, a substantial number of plasmids contained DNA inserts smaller than 400 bp, which are difficult to detect on agarose gels. Based on these data, the number of transformants, and a genomic (5 ,ul, optical density at 600 nm of 5 for sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting) of the following heat-induced strains: a, S1036; b, S1143; c, S1142; d, S1141; e, S1140; f, S1130; g, S1129; h, S1123; i, S1120; j, S1119; k, S1116; 1, S1115; m, S1114; n, S1113. The Western blot was developed with a pool of 19 sera from household contacts; the sera were absorbed as described in Materials and Methods. size of 3.3 x 103 kbp for M. leprae (10) , each pEX1-, pEX2-, or pEX3-derived recombinant contained three to six mycobacterial genome equivalents.
Selection of recombinants. About 1.7 x 105 colonies of the M. leprae gene libraries in pEX1, pEX2, and pEX3 were screened with the absorbed contact serum pool. We selected 36 potentially positive recombinants. These recombinants were characterized with respect to DNA inserts and expression products. Recombinant plasmids contained inserts ranging in size from 0.2 to 2.5 kbp. All recombinants expressed M. leprae antigens as fusion proteins with ,-galactosidase, with apparent molecular weights ranging from 116,000 (116K proteins) to 145,000 (145K proteins). Western blot analysis revealed that 12 of the recombinants produced antigens that clearly reacted more strongly with antibodies in the sera from contacts than did the control antigen, cro-,Bgalactosidase, produced by strain S1036 (Fig. 1) sodium dodecyl sulfate-polyacrylamide gels and Western blots (Fig. 1 ). Nucleotide and deduced amino acid sequences. To characterize the recombinant antigens, we determined part of the nucleotide sequence of one strand of the various DNA inserts, adjacent to lacZ (Fig. 2) . Both strands of the small inserts of plasmids pTHL1034 and pTHL1038 were sequenced. The correct reading frame of the M. leprae part of the fused genes could be derived from the reading frame of the lacZ counterpart (18) . The coding regions of the various established DNA sequences had an overall G+C content of 60% or more ( Table 1) . The established sequences shown in Fig. 2 do not have regions of homology and thus represent different antigenic determinants. Moreover, as can be deduced from the apparent molecular weights (Table 1 ) and the established DNA sequences (Fig. 2) , eight of the recombinant plasmids (pTHL1031, pTHL1034, pTHL1037, pTHL1038, pTHL1055, pTHL1056, pTHL1057, and pTHL1058) encode C-terminal parts of different antigens, suggesting that a high percentage of the recombinants expressed different M. leprae antigens. Consistent with this, dot blot hybridizations revealed that none of the DNA inserts hybridized to DNA from a pEX clone other than its own (data not shown). Apparently, the pEX-derived plasmids contained distinct DNA inserts. Therefore, we conclude that the selected recombinants expressed parts of different antigens. 1 GATCAGCCAGTCCAGGCTCATGCCGTCCTTCGCGAAAATGCGCAGAAGCTGTTCGAGGTG 60
61 GGCCAGGTCGGGAATGCCGTAGTTCAGTACGCTGGCGGCGACGTAGGGATGCGCCTCGAG 120
Nucleotide sequence and deduced amino acid sequence of a part of the M. leprae DNA inserts of the various hybrid plasmids encoding M. leprae antigenic determinants recognized by contacts' sera. The DNA sequence of the part of the inserts adjacent to lacZ was determined for one strand by using primers S10 and 86.25-2. Primer 17.5.88-2 was used to sequence the complementary strands of the inserts of plasmids pTHL1034 and pTHL1038. Boldface type indicates nucleotides belonging to the vector or the BamHI-Sau3A cloning sites.
pTHL1033 contains a mutation at the cloning site; the first nucleotide in the sequence belongs to the vector. The translation of all nucleotide sequences is in accordance with the open reading frame of lacZ in the pEX plasmids.
BCG; and the a antigen of Mycobacterium kansasii (23) . In antigens are related at the protein level. To investigate such all cases, the complementary strands were also involved in a relationship, deduced translation products of all genes as the comparisons. No significant homology was found with well as the amino acid sequence of the tuberculin-active any of these genes. Consequently, none of the cloned protein of M. tuberculosis (20) No significant homologies between any one of these translation products and any of the other mycobacterial antigens were found.
Taking these results together, we conclude that the recombinant M. leprae antigens selected with sera from contacts are not homologous or related to any other well-characterized mycobacterial antigen.
Reactivity of recombinant antigens with individual sera. To investigate which of the sera in the pool contained antibodies to the fusion proteins expressed by the selected recombinants, lysates of these recombinant clones were subjected to Western blotting with the individual sera as probes. Based on the results from the Western blotting experiments, the antigens could be divided into two groups. Group 1 antigens showed a weak reaction with all tested sera, i.e., S1113, S1114, S1115, S1116, S1119, S1123, S1141, S1142, and S1143. Group 2 antigens reacted strongly with a limited number of sera, i.e., S1120 (reacting with serum c), S1129 (reacting with sera e, h, m, and n), and S1130 (reacting with serum k). As typical examples for each group of antigens, Western blots of lysates of S1143 (group 1) and S1120 (group 2) are shown in Fig. 3 . DISCUSSION In this paper we report the selection and characterization of several antigenic determinants of M. leprae that are recognized by sera from well-documented contacts of leprosy patients. For this selection, we constructed a genomic library of DNA from nonirradiated M. leprae.
The previously described lambda gtll::M. leprae expression library (45) was shown to contain a relatively high percentage of a number of identical recombinants (37; unpublished observations). This is probably caused by effective multiplication of these recombinants during amplification of the library. Recombinants with a low replication rate are present in low numbers in the library and hence can easily be missed in the screening. Instead of using an amplified library, we preferred to construct a new expression library and to use it without significant amplification in the screening procedure.
From this library we selected 12 recombinants that produced antigenic determinants clearly recognized by sera from contacts on Western blots. All antigens were produced as fusion proteins ranging from 116K to 145K. This means that parts of 2K to 31K M. leprae antigens were expressed by the various recombinants. The corresponding DNA inserts had sufficient coding capacities.
To further characterize the recombinant antigens, we established the nucleotide sequence of a 84-to 180-bp segment of the various inserts adjacent to lacZ. Based on these nucleotide sequences and on the apparent molecular weights of the recombinant antigens, as well as on the results of DNA hybridizations, we conclude that all 12 recombinants probably encode different antigens. One of seven recombinants showing conjugate binding in the absence of serum was characterized in a similar way (S1140). Whether such expressed recombinants might bind to the Fc part of immunoglobulins needs further investigation.
Screening of M. leprae libraries with sera of leprosy patients (9, 29) or their contacts (this report) has resulted in the selection of recombinants producing a variety of antigens. A relatively large number of antigens had been identified earlier in M. leprae by using blotting techniques (8, 11, 19) . In contrast, murine monoclonal antibodies have predominantly recognized six antigens, 12K, 18K, 28K, 36K, 65K, and 70K (39), which have also been frequently selected from recombinant libraries. This discrepancy in the number of antigens recognized by murine monoclonal antibodies and human sera might be a reflection of both quantitative and qualitative differences in their immune responses to M. leprae.
Comparison of nucleotide and amino acid sequences of the contact clones did not reveal any significant homology with other well-characterized antigens from M. leprae or from other mycobacteria, including the 12K, 18K, 65K, and 70K heat shock proteins (33, 39, 44) . Apparently, the sera contained only limited amounts of antibodies to these heat shock proteins. At first glance this seems surprising, since these stress-related proteins are supposed to be major immunological targets (44) and antibody responses to some of these antigens have been reported in leprosy patients (25) . A possible explanation for the absence of heat shock proteinproducing recombinants could be that heat shock proteins form a well-conserved group of molecules also present in E.
VOL. 58, 1990 on November 6, 2017 by guest http://iai.asm.org/ Downloaded from coli (33, 36) . Hence, cross-reactive antibodies against heat shock proteins have very likely been depleted during the absorption step. In agreement with this explanation, no heat shock protein-producing recombinants could be selected with E. coli-absorbed patient sera (29) . On the other hand, it might be possible that no such antibodies are present in most sera from contacts.
Two groups of recombinant antigens could be distinguished: one group was recognized by the sera of all contacts used in this study; the other group was recognized by the sera of only a limited number of contacts. Apparently, some mycobacterial antigenic determinants are capable of inducing antibody responses independent of host-related factors, whereas others are not.
In this study we describe the identification of M. leprae antigenic determinants that may play a role at the early stage of infection. Household contacts used in this study have lived in the close vicinity of untreated lepromatous leprosy patients for long periods and are very likely to be infected with M. leprae. The contacts have not been vaccinated with M. bovis BCG. Therefore, we assume that the antibodies present in the absorbed sera are the products of a humoral response to M. leprae. However, the possibility cannot be excluded that a portion of the antibodies is directed to cross-reactive determinants and results from a response to other mycobacteria. The established DNA sequences had a G+C content that was much higher than that reported for the M. leprae genome and more comparable to those of a number of other mycobacteria (10, 17) . Although the sequenced parts of the genes may not be representative for the complete genes, this might indicate that the expressed M. leprae determinants are not specific for this bacillus but could be common in a number of other pathogenic and nonpathogenic mycobacteria.
The contacts used in this study have not yet developed leprosy, which suggests that they have some form of immunity to the disease. As a continuation of this study, complete genes of contact antigens will be selected from a cosmid library. Reactivity patterns of sera of leprosy patients and their contacts with the complete recombinant antigens, as well as T-cell responses to these antigens, will be determined.
The available methodology for the study of infection with M. leprae and immunity to such infection is inadequate. The recent development of a polymerase chain reaction for the sensitive and specific detection of M. leprae (15) has opened wider perspectives for the future. In this report we describe previously unidentified antigens, which may be relevant to immune responses during the early phase of infection. The combination of studies of infection and immunity should provide valuable information and contribute to the development of tools necessary for the eradication of leprosy.
